Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kv7 channels, also known as KCNQ channels, are a family of voltage-gated potassium (K+) channels encoded by the KCNQ1–KCNQ5 genes. These channels play critical roles in regulating cellular excitability in various tissues including the heart, brain, muscles (smooth and skeletal), sensory cells (auditory and vestibular organs), and epithelia. They are tetrameric assemblies of six-transmembrane-segment α-subunits, with S1–S4 forming the voltage-sensing domain (VSD) and S5–S6 forming the pore domain. Activation is voltage-dependent and requires PIP2. Dysfunction leads directly to major neurological and cardiovascular disorders.
Enhances Kv7 channel activity, stabilizing resting membrane potential
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium Voltage-Gated Channel Subfamily Q Member (Kv7).